Latest Insider Transactions at Predictive Oncology Inc. (POAI)
This section provides a real-time view of insider transactions for Predictive Oncology Inc. (POAI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Predictive Oncology Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Predictive Oncology Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,704
+29.11%
|
-
|
|
Jul 01
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,704
+31.46%
|
-
|
|
Jul 01
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+33.81%
|
-
|
|
Jul 01
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,704
+11.9%
|
-
|
|
Jul 01
2022
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+30.57%
|
-
|
|
Jul 01
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+28.04%
|
-
|
|
May 26
2022
|
Daniel E Handley Director |
BUY
Open market or private purchase
|
Direct |
2,550
+4.88%
|
$0
$0.37 P/Share
|
|
May 25
2022
|
Daniel E Handley Director |
BUY
Open market or private purchase
|
Direct |
2,800
+5.61%
|
$0
$0.35 P/Share
|
|
May 24
2022
|
J Melville Engle |
BUY
Open market or private purchase
|
Direct |
159,500
+43.95%
|
$0
$0.37 P/Share
|
|
May 20
2022
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
16,125
+29.07%
|
$0
$0.3 P/Share
|
|
May 20
2022
|
Charles Lee Sr Nuzum Director |
BUY
Open market or private purchase
|
Direct |
200,000
+41.14%
|
$0
$0.31 P/Share
|
|
Mar 31
2022
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+13.23%
|
-
|
|
Mar 31
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,530
+11.74%
|
-
|
|
Mar 31
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+16.83%
|
-
|
|
Mar 31
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+12.17%
|
-
|
|
Mar 31
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,530
+9.01%
|
-
|
|
Mar 31
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+10.44%
|
-
|
|
Jan 04
2022
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+30.11%
|
-
|
|
Jan 04
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,775
+36.06%
|
-
|
|
Jan 04
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+27.81%
|
-
|
|
Jan 04
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+24.01%
|
-
|
|
Jan 04
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,517
+36.17%
|
-
|
|
Jan 04
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+37.78%
|
-
|
|
Jan 04
2022
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
20,428
+31.76%
|
-
|
|
Oct 01
2021
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,512
+32.17%
|
-
|
|
Oct 01
2021
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
4,512
+18.84%
|
-
|
|
Oct 01
2021
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,265
+15.61%
|
-
|
|
Oct 01
2021
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,512
+15.77%
|
-
|
|
Oct 01
2021
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
4,512
+16.13%
|
-
|
|
Oct 01
2021
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,265
+16.44%
|
-
|
|
Oct 01
2021
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,512
+16.13%
|
-
|
|
Sep 23
2021
|
Robert L Myers CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,200
-30.53%
|
$10,200
$1.13 P/Share
|
|
Sep 23
2021
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
33,334
+49.94%
|
$33,334
$1.13 P/Share
|
|
Sep 13
2021
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jul 01
2021
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,995
+33.65%
|
-
|
|
Jul 01
2021
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+39.94%
|
-
|
|
Jul 01
2021
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+34.37%
|
-
|
|
Jul 01
2021
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+33.64%
|
-
|
|
Jul 01
2021
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+34.37%
|
-
|
|
Jul 01
2021
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,995
+35.36%
|
-
|
|
Apr 21
2021
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 01
2021
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,887
+33.62%
|
-
|
|
Apr 01
2021
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,887
+37.28%
|
-
|
|
Apr 01
2021
|
Richard L Gabriel Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+22.55%
|
-
|
|
Apr 01
2021
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+35.45%
|
-
|
|
Apr 01
2021
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+35.45%
|
-
|
|
Apr 01
2021
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+33.93%
|
-
|
|
Feb 24
2021
|
Carl I. Schwartz Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
100,401
+5.54%
|
$100,401
$1.43 P/Share
|
|
Oct 22
2020
|
Carl I. Schwartz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
640
-0.04%
|
$0
$0.85 P/Share
|